
GIVE THE PERFECT GIFT
Erin Mills Town Centre Gift Cards are the perfect choice for your gift giving needs.Purchase gift cards at kiosks near the food court or centre court, at Guest Services, or click below to purchase online.PURCHASE HEREHome
Alzheimer's Disease-Associated Cognitive Disabilities
Indigo
Loading Inventory...
Alzheimer's Disease-Associated Cognitive Disabilities
Current price: $64.49
Original price: $80.62


Alzheimer's Disease-Associated Cognitive Disabilities
Current price: $64.49
Original price: $80.62
Loading Inventory...
Size: Kobo eBook
*Product information may vary - to confirm product availability, pricing, shipping and return information please contact Indigo
This book offers a comprehensive exploration of cognitive disabilities, particularly associated with Alzheimer's disease (AD), primarily focusing on understanding, diagnosing, managing, and advancing the treatment of these impairments. The scope of this book extends beyond existing strategies by offering research-focused content, including diagnostic tools, emerging treatment modalities, and the latest developments in nanotechnology and artificial intelligence (AI) for the management of AD-associated cognitive disabilities. The book&s unique viewpoint on the diagnosis and therapeutic management of cognitive disabilities as the primary focus of Alzheimer's pathology makes it an indispensable resource for neuroscientists, cognitive researchers, and medical professionals. By connecting clinical insights with current research, the book provides readers with a deeper understanding of the disease&s mechanisms, which can be applied for related clinical or research purposes.
This book offers a comprehensive exploration of cognitive disabilities, particularly associated with Alzheimer's disease (AD), primarily focusing on understanding, diagnosing, managing, and advancing the treatment of these impairments. The scope of this book extends beyond existing strategies by offering research-focused content, including diagnostic tools, emerging treatment modalities, and the latest developments in nanotechnology and artificial intelligence (AI) for the management of AD-associated cognitive disabilities. The book&s unique viewpoint on the diagnosis and therapeutic management of cognitive disabilities as the primary focus of Alzheimer's pathology makes it an indispensable resource for neuroscientists, cognitive researchers, and medical professionals. By connecting clinical insights with current research, the book provides readers with a deeper understanding of the disease&s mechanisms, which can be applied for related clinical or research purposes.



















